IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 335 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $423,163 | -11.4% | 9,329 | -19.8% | 0.89% | +20.0% |
| Q2 2023 | $477,425 | +8.2% | 11,636 | -5.7% | 0.74% | +14.8% |
| Q1 2023 | $441,175 | -15.8% | 12,344 | -11.0% | 0.64% | -3.6% |
| Q4 2022 | $524,059 | -32.8% | 13,875 | -21.3% | 0.67% | -12.8% |
| Q3 2022 | $780,000 | +16.1% | 17,628 | -2.9% | 0.77% | +23.9% |
| Q2 2022 | $672,000 | -25.8% | 18,146 | -9.9% | 0.62% | +53.0% |
| Q1 2021 | $906,000 | +105.0% | 20,146 | +157.7% | 0.40% | +86.2% |
| Q4 2020 | $442,000 | – | 7,817 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |